Key statistics
As of last trade, Biora Therapeutics Inc (BIOR:NMQ) traded at 1.60, 11.89% above the 52 week low of 1.43 set on Nov 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.62 |
---|---|
High | 1.65 |
Low | 1.59 |
Bid | 1.56 |
Offer | 1.60 |
Previous close | 1.63 |
Average volume | 151.13k |
---|---|
Shares outstanding | 4.34m |
Free float | 4.33m |
P/E (TTM) | -- |
Market cap | 7.07m USD |
EPS (TTM) | -12.92 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 17:17 GMT.
More ▼
- Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
- Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update
- Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting
- Biora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting
- Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium
- Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024
- Biora Therapeutics Achieves ISO 13485 Certification
- Biora Therapeutics Announces Positive Nasdaq Listing Decision
- Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
More ▼